Dana Wolf serves as Executive at Artemis Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dana Wolf has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 26, 2017 involved exercising options for 35,202 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 26, 2017 | ATMS | $0 | Option Exercise | 35,202 | $N/A | Discretionary |
Dana Wolf currently holds 35,202 shares of Artemis Therapeutics, Inc. (ATMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dana Wolf has been a net neutral trader of ATMS stock. They have purchased $0 and sold $0 worth of shares.
Dana Wolf's most recent insider trade was on Jun 26, 2017, when they sold 35,202 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted